Janux Therapeutics (NASDAQ:JANX – Get Free Report) and VYNE Therapeutics (NASDAQ:VYNE – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation. Volatility & Risk Janux Therapeutics has a […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 2,940,000 shares, an increase of 7.3% from the April 15th total of 2,740,000 shares. Based on an average daily trading volume, of 69,500 shares, […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 2,940,000 shares, a growth of 7.3% from the April 15th total of 2,740,000 shares. Based on an average daily trading volume, of 69,500 shares, […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) – Equities researchers at HC Wainwright issued their Q1 2024 earnings estimates for Janux Therapeutics in a research report issued to clients and investors on Wednesday, May 10th. HC Wainwright analyst S. Ramakanth expects that the company will post earnings per share of ($0.57) for the quarter. HC […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) – Research analysts at HC Wainwright lifted their Q2 2023 earnings estimates for shares of Janux Therapeutics in a research report issued to clients and investors on Wednesday, May 10th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($0.51) per share for the quarter, […]